EPAS1 knockdown is associated with cell cycle and DNA replication programs and MYC/E2F-related signatures in hemangioma endothelial cells
Open Access
- 24 July 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354272
Abstract
Infantile hemangioma (IH) is the most common benign tumor of infancy. Hypoxia and activation of hypoxia-inducible factor (HIF) signaling have been proposed to contribute to IH pathogenesis, yet the role of endothelial PAS domain-containing protein 1 ( EPAS1 ), which encodes hypoxia-inducible factor-2α (HIF-2α), in hemangioma endothelial cells (HemECs) remains less well characterized. Here, we investigated HIF-2α in primary HemECs using a pharmacological inhibitor (PT-2399) and shRNA-mediated EPAS1 knockdown under normoxic and hypoxic conditions. In hypoxic cultures, PT-2399 treatment was associated with reduced migration and invasion and with a reduction in junction number in tube formation assays; at the selected dose, PT-2399 did not significantly reduce cell viability. By contrast, EPAS1 knockdown was associated with reduced proliferative capacity and altered cell cycle distribution, together with enrichment of DNA replication/cell cycle-related transcriptional programs, negative enrichment of MYC- and E2F-related gene sets, and directionally consistent protein level changes in selected regulators. EPAS1 knockdown-associated phenotypic trends were broadly similar under normoxia and hypoxia, with no clear evidence that hypoxic stimulation enhanced the magnitude of these changes. In IH tissue transcriptomic data, Egl-9 family hypoxia-inducible factor 3 ( EGLN3 ) showed reduced expression, consistent with a testable hypothesis that hypoxia-independent mechanisms may contribute to maintenance of HIF-2α activity in this context. This study is limited by the use of HemECs derived from a single IH specimen and by the absence of on-target validation; accordingly, the findings should be interpreted as exploratory and hypothesis-generating.Keywords
Funding Information
- National Natural Science Foundation of China (82372537)
This publication has 25 references indexed in Scilit:
- Apolipoprotein A-I Binding Protein Inhibits the Formation of Infantile Hemangioma through Cholesterol-Regulated Hypoxia-Inducible Factor 1α ActivationJournal of Investigative Dermatology, 2023
- Revisiting the HIF switch in the tumor and its immune microenvironmentTrends in Cancer, 2021
- Infantile haemangiomaThe Lancet, 2017
- Hypoxia, Hypoxia-inducible Transcription Factors, and Renal CancerEuropean Urology, 2016
- HIF‐2 Inhibition Supresses Inflammatory Responses and Osteoclastic Differentiation in Human Periodontal Ligament CellsJournal of Cellular Biochemistry, 2015
- Passing the baton: the HIF switchTrends in Biochemical Sciences, 2012
- Characteristics of Infantile Hemangiomas as Clues to PathogenesisArchives of Dermatology, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and ProliferationCancer Cell, 2007
- HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional ActivityCancer Cell, 2007